Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly.
Aart J van der LelyRoy GomezAndreas PleilXavier BadiaThierry BrueMichael BuchfelderPia BurmanDavid ClemmonsEzio GhigoJens Otto Lunde JørgensenAnton LugerJoli van der Lans-BussemakerSusan M WebbChristian J StrasburgerPublished in: Pituitary (2018)
The validation study underlined IGF-I and tumor status for routine clinical decision-making, whereas patient-oriented outcome measures received less medical attention. An Acromegaly Disease Activity Tool (ACRODAT) is in development that might assist clinicians towards a more holistic approach to patient management in acromegaly.